Aqueous zinc ion batteries (AZIBs) are one of the most well-liked power source systems at present because of their low price and elevated security. However, AZIBs still face challenges such as zinc dendrite formation, hydrogen evolution, and corrosion. Therefore, this work achieves high-performance dendrite-free AZIBs (Zn@MIL-101-NH2) by constructing a highly three-dimensional porous Cr-based metal–organic framework (MIL-101-NH2) artificial interface protection layer. MIL-101 has a highly three-dimensional porous structure, and –NH2 groups are introduced. –NH2, which is hydrophilic and zincophilic, reconfigures the hydrogen-bonding network structure around the artificial interfacial layer, inhibits the occurrence of the hydrogen precipitation reaction, and induces the uniform deposition of zinc ions. According to experimental results, the Zn@MIL-101-NH2 full cell may retain up to 89.6% of its capacity after 1400 cycles at a current density of 1.0 A g−1, demonstrating excellent electrochemical performance.
22 January 2026 in Journal of Materials Chemistry A
Attributed to the abundant polar functional groups and 3D crosslinked network, the CS/Gel protective layer can effectively accelerate the Zn 2+ desolvation behavior and homogenize the zinc ion flux, thus realizing stable zinc anodes.
Community-acquired pneumonia (CAP) is a leading cause of death from infectious diseases in adults worldwide. Traditional Chinese medicine injections (TCMIs) are often used as complementary therapies. This study aimed to evaluate the efficacy and safety of TCMIs for the treatment of CAP. A step-by-step strategy was first designed including data collection, systematic review, Bayesian network meta-analysis (NMA), and assessment of the NMA. Eight databases were searched for relevant randomized clinical trials (RCTs) from their inception to December 31, 2022. The Cochrane risk-of-bias tool was used to assess the methodological quality and the risk of bias of the included RCTs. Bayesian NMA was performed by WinBUGS 14.0 and STATA 15.0. Finally, the Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) system was used to evaluate the quality of evidence for each outcome. A total of 35 RCTs involving 4 291 participants were included. For clinical effectiveness rate, the Reduning Injection (RDN) combined with Western medicine (WM) was the most likely to be the best treatment (SUCRA = 0.919). And the top three TCMIs interventions were RDN + WM, Xiyanping Injection (XYP) + WM, Tanreqing injection (TRQ) + WM. For defervescence time, disappearance time of cough, and the disappearance time of lung rales, the XYP with WM was probably the best treatment (SUCRA = 0.822, 0.838, 0.816). Moreover, adverse drug reactions have been reported in 14 RCTs. The TCMIs can effectively relieve clinical symptoms and improve clinical efficiency than that of WM alone for adults with non-severe CAP. Step-by-step results firstly indicated that XYP with WM was superior treatment regimen to reduce defervescence time, disappearance time of cough and disappearance time of lung rales. For safety, the mild adverse drug reactions occurred during the entire course of therapy and were self-limiting, further confirming the favorable safety profile of the TCMIs.
5 July 2025 in Applied Biochemistry and Biotechnology